Registration Dossier

Administrative data

Key value for chemical safety assessment

Effects on fertility

Link to relevant study records
Reference
Endpoint:
screening for reproductive / developmental toxicity
Remarks:
based on test type (migrated information)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
October-December 2013
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study has been performed according to OECD test guideline and in compliance with GLP principles.
Qualifier:
according to
Guideline:
OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
Version / remarks:
(1995)
Deviations:
no
Qualifier:
according to
Guideline:
other: OPPTS 870.3550 Reproduction/Developmental toxicity Screening test (2000)
Deviations:
no
GLP compliance:
yes
Limit test:
no
Species:
rat
Strain:
other: Crl:WI(Han)
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany
- Age at study initiation: 11 weeks
- Weight at study initiation: (P) Males: 269-299 g; Females: 192-225 g
- Fasting period before study: not applicable
- Housing: Animals were housed in groups of 5 animals/sex/cage in Macrolon plastic cages (home cage) before mating. Females were caged together with males on a one-to-one basis in Marcolon plastic cages for mating. After mating, males were housed in their home cage, females were individually housed in Macrolon plastic cages. Pups were kept with the dam until termination.
- Diet: Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany).
- Water: Free access to tap water
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-24
- Humidity (%): 40-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 08 October To: 2 December 2013
Route of administration:
oral: gavage
Vehicle:
propylene glycol
Remarks:
specific gravity 1.036
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:
Formulations (w/w) were prepared daily within 6 hours prior to dosing and were homogenized to a visually acceptable level. Adjustment was made
for specific gravity of the vehicle. No correction was made for the purity/composition of the test substance.
Dose volume: 5 mL/kg body weight. Actual dose volumes were calculated according to the latest body weight.

VEHICLE
- Justification for use and choice of vehicle (if other than water): Based on trial formulations performed at WIL Research Europe.

Details on mating procedure:
- M/F ratio per cage: 1/1 (one female was cohabitated with one male of the same treatment group, avoiding sibling mating).
- Length of cohabitation: A maximum of 14 days was allowed for mating.
- Proof of pregnancy: Detection of mating was confirmed by evidence of sperm in vaginal lavage or by the appearance of an intravaginal copulatory plug referred to as Day 0.
- After successful mating each pregnant female was caged: see details on test animals and conditions
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Analyses were conducted on a single occasion during the treatment phase, according to a validated method (Project 503717). Samples of formulations were analyzed for homogeneity (highest and lowest concentration) and accuracy of preparation (all concentrations). Stability in vehicle over 6 hours at room temperature was also determined (highest and lowest concentration).
The accuracy of preparation was considered acceptable if the mean measured concentrations were 85-115% of the target concentration. Homogeneity was demonstrated if the coefficient of variation was ≤ 10%. Formulations were considered stable if the relative difference before and after storage was maximally 10%.
Duration of treatment / exposure:
Males were exposed for 28 days, i.e. 2 weeks prior to mating, during mating, and up to the day prior to scheduled necropsy. Females were exposed for 41-55 days, i.e. during 2 weeks prior to mating, during mating, during post-coitum, and during at least 4 days of lactation (up to the day prior to scheduled necropsy). 2 Females of Group 1, one females of group 3 and one of group 4 were not dosed on Day 1 of lactation as these females were littering at the time of dosing. The omission of one day of dosing over a period of several weeks was not considered to affect the toxicological evaluation.
Frequency of treatment:
1/day, 7 d/wk
Details on study schedule:
- Age at mating of the mated animals in the study: Approximately 13 weeks
Remarks:
Doses / Concentrations:
0, 100, 300, 1000 mg/kg bw/d
Basis:
actual ingested
No. of animals per sex per dose:
10
Control animals:
yes, concurrent vehicle
Details on study design:
- Dose selection rationale: Dose levels were selected based on a 28-day oral toxicity study (HRC study no. MIN 35/91509) in which 0, 10, 100 and 1000 mg/kg bw/day were dosed by oral gavage to five rats/sex/group. At 1000 mg/kg bw/day, the following findings were noted: increased water consumption for females, reduced lymphocyte and total white blood cell counts for one female rat, higher adrenal and liver weights for females, and minimal centrilobular hepatocyte enlargement in the liver of one female. At 100 mg/kg bw/day, a slight increase in water consumption was recorded for females. No findings were noted at 10 mg/kg bw/day.
- Other: Based on these results, the liver and adrenals were weighed and collected during this project.

Parturition:
The females were allowed to litter normally. Day 1 of lactation was defined as the day when a litter was found completed (i.e. membranes and placentas cleaned up, nest build up and/or feeding of pups started). Females that were littering were left undisturbed.

Pups:
On Day 1 of lactation, all pups were individually identified by means of subcutaneous injection of Indian ink. Pups were not dosed directly but could have potentially be exposed to the test substance in utero, via maternal milk or from exposure to maternal urine/faeces.

Selection of animals for selected measurements:
5 animals/sex/dose were randomly selected at allocation for functional observations, clinical pathology, macroscopic examination, organ weights and histopathology. Only females with live offspring were selected.
Positive control:
not applicable
Parental animals: Observations and examinations:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: at least twice daily

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: At least once daily from start of treatment onwards up to the day prior to necropsy, detailed clinical observations were made in all animals. The time of onset, grade and duration of any observed sign was recorded.

BODY WEIGHT: Yes
- Time schedule for examinations: Males and females were weighed on the first day of exposure and weekly thereafter. Mated females were weighed on Days 0, 4, 7, 11, 14, 17 and 20 post-coitum and during lactation on Days 1 and 4.

FOOD CONSUMPTION: Yes
- Time schedule: Weekly, except for males and females which were housed together for mating and for females without evidence of mating. Food consumption of mated females was measured on Days 0, 4, 7, 11, 14, 17 and 20 postcoitum and on Days 1 and 4 of lactation.

WATER CONSUMPTION: Yes
Subjective appraisal was maintained during the study, but no quantitative investigation was introduced as no treatment related effect was suspected.

OTHER: General reproduction data
Male number paired with, mating date, confirmation of pregnancy, and delivery day were recorded. Pregnant females were examined to detect signs of difficult or prolonged parturition, and cage debris of pregnant females was examined to detect signs of abortion or premature birth. Any deficiencies in maternal care (such as inadequate construction or cleaning of the nest, pups left scattered and cold, physical abuse of pups or apparently inadequate lactation or feeding) were examined.
Litter observations:
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities

- Mortality/viability: The numbers of live and dead pups on Day 1 of lactation and daily thereafter were determined. If possible, defects or cause of death were evaluated. (Animals showing pain, distress or discomfort, which was considered not transient in nature or was likely to become more severe, were sacrificed for humane reasons based on OECD guidance document on humane endpoints (ENV/JM/MONO/ 2000/7).)
- Clinical signs: At least once daily, detailed clinical observations were made for all animals.
- Body weights: Live pups were weighed on Days 1 and 4 of lactation.
- Sex: Sex was determined for all pups on Days 1 and 4 of lactation (by assessment of ano-genital distance).

GROSS EXAMINATION OF DEAD PUPS:
Yes, if necessary, defects or cause of death were evaluated.
Postmortem examinations (parental animals):
SACRIFICE and gross necropsy:
The animals were not deprived of food overnight. All animals surviving to the end of the observation period were deeply anaesthetized using isoflurane and subsequently exsanguinated and subjected to an external, thoracic and abdominal examination, with special attention being paid to the reproductive organs. Descriptions of all macroscopic abnormalities were recorded.

The numbers of former implantation sites and corpora lutea were recorded for all paired females.

HISTOPATHOLOGY/ORGAN WEIGHTS:
Adrenals, epididymides, liver and testes

HISTOPATHOLOGY:
According to the guidelines. Staging of spermatogenesis was examined for control and 1000 mg/kg bw/day dosed males and all males suspected to be infertile.
Postmortem examinations (offspring):
SACRIFICE
Pups surviving to planned termination were killed by decapitation on Days 5-6 of lactation. One pup (300 mg/kg bw/d group) was killed in extremis on Day 4 of lactation by decapitation.

GROSS NECROPSY
All pups were sexed and descriptions of all external abnormalities were recorded. At discretion of the Study Director, relevant abnormalities were collected and fixed in 10% buffered formalin; this was done for one pup from the mid dose group (300 mg/kg bw/day) that showed a wound on the left flank and had to be euthanized in extremis If possible, defects or cause of death were evaluated.

HISTOPATHOLOGY / ORGAN WEIGTHS
No
Statistics:
The following statistical methods were used to analyze the data:
- If the variables could be assumed to follow a normal distribution, the Dunnett-test based on a pooled variance estimate was applied for the comparison of the treated groups and the control groups for each sex.
- The Steel-test was applied if the data could not be assumed to follow a normal distribution.
- The Fisher Exact-test was applied to frequency data.
All tests were two-sided and in all cases p < 0.05 was accepted as the lowest level of significance.
Group means were calculated for continuous data and medians were calculated for discrete data (scores) in the summary tables. Test statistics were calculated on the basis of exact values for means and pooled variances. Individual values, means and standard deviations may have been rounded off before printing. Therefore, two groups may display the same printed means for a given parameter, yet display different test statistics values.
Reproductive indices:
For each group, the following calculations were performed:
-Mating index (%): (Number of females mated/Number of females paired) x 100
-Fertility index (%): (Number of pregnant females/Number of females paired) x 100
-Conception index (%): (Number of pregnant females/Number of females mated) x 100
-Gestation index (%): (Number of females bearing live pups/Number of pregnant females) x 100
-Duration of gestation: Number of days between confirmation of mating and the beginning of parturition
Offspring viability indices:
-Percentage live males at First Litter Check: (Number of live male pups at First Litter Check/Number of live pups at First Litter Check) x 100
-Percentage live females at First Litter Check: (Number of live female pups at First Litter Check/Number of live pups at First Litter Check) x 100
-Percentage of postnatal los: (Number of dead pups before planned necropsy/Number of live pups at First Litter Check) x 100
-Viability index: (Number of live pups before planned necropsy/Number of pups born alive) x 100
Clinical signs:
no effects observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Histopathological findings: non-neoplastic:
no effects observed
Other effects:
not examined
Description (incidence and severity):
Test substance intake: not relevant
Reproductive function: oestrous cycle:
not examined
Reproductive function: sperm measures:
no effects observed
Reproductive performance:
no effects observed
CLINICAL SIGNS AND MORTALITY (PARENTAL ANIMALS)
No mortality occured.
No treatment related clinical signs of toxicity were noted during the observation period. Incidental findings that were noted included scabbing, a wound, and alopecia. These findings occurred within the range of background findings to be expected for rats of this age and strain which are housed
and treated under the conditions in this study. At the incidence observed, these were considered signs of no toxicological relevance.

BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
Body weights and body weight gain of treated animals remained in the same range as controls over the treatment period.
Food consumption before or after allowance for body weight was similar between treated and control animals.

REPRODUCTIVE FUNCTION: SPERM MEASURES (PARENTAL ANIMALS)
Spermatogenic staging profiles were normal for all males examined.

REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
No toxicologically relevant effects on reproductive parameters were noted.
Mating, fertility and conception indices, precoital time, and number of corpora lutea and implantation sites were unaffected by treatment. A total of eight mated females were not pregnant: four in the control group, two treated at 100 mg/kg bw/day and two treated at 300 mg/kg bw/day which resulted in decreased fertility and conception indices for the control group. This was considered a chance finding and not treatment related as it mostly concerned the control group and at 1000 mg/kg bw/day all females were pregnant. For a thorough evaluation of all reproduction data, historical control data were added to the report. The statistically significant increase for number of corpora lutea at 1000 mg/kg bw/day was not considered toxicologically relevant as all values were within normal limits, with the control group at the lower end.

ORGAN WEIGHTS (PARENTAL ANIMALS)
No toxicologically relevant changes were noted in organ weights and organ to body weight ratios.
The statistically significant increase noted for liver weights and liver to body weight ratios for females treated at 1000 mg/kg were not considered toxicologically relevant as this change was due to their pregnancy status (there were four non-pregnant animals in the control group, two in both the low and mid dose groups and none in the high dose group). The mean liver weights were calculated for 10 females per group (pregnant and non-pregnant). When looking at the individual values for female liver weights, the non-pregnant females have a lower weight (which is normal for their physiological state). When excluding these non-pregnant values, the mean values for liver weights are 10.34, 10.84, 10.61 and 11.00 gram and for liver to body weight ratios are 3.85%, 4.11%, 3.94% and 4.09% for Groups 1, 2, 3 and 4, respectively.
The statistically significantly change noted for relative liver weight for males treated at 100 mg/kg was not considered toxicologically relevant as no dose response was noted and all values were within normal limits.

GROSS PATHOLOGY (PARENTAL ANIMALS)
Macroscopic observations at necropsy did not reveal any alterations that were considered to have arisen as a result of treatment.
The incidence of incidental findings among control and treated animals was within the background range of findings that are encountered among rats of this age and strain, and did not show a dose related incidence trend. These necropsy findings were therefore considered to be of no toxicological
relevance, and included pelvic dilation of the kidneys, nodule at the epididymides, scabbing, uterus containing fluid, focus on the clitoral glands or thymus, alopecia, enlarged adrenals or clitoral glands, diaphragmatic hernia of the liver, and discolouration of the clitoral glands.

HISTOPATHOLOGY (PARENTAL ANIMALS)
There were no test item-related microscopic findings.
There were four pairs of the 0 mg/kg bw/day group, two pairs of the 100 mg/kg bw/day group and two pairs of the 300 mg/kg bw/day group that failed to sire or deliver healthy pups. All findings recorded in the reproductive organs of these animals were within the normal range of background pathology. Spermatogenic staging profiles were normal for all males examined.
All microscopic findings recorded were considered to be within the normal range of background pathology encountered in rats of this age and strain.

OTHER FINDINGS (PARENTAL ANIMALS)
A minimum of eight pregnant females per group is advised by the OECD 421 test guideline. For the concurrent control group however, only six females were pregnant. These females also had nests with a mean sex ratio that fell outside the historical control data range. The small number of pregnant
females, slightly high mean/median precoital time, slightly low number of corpora lutea and implantation sites, relatively small litter sizes, and the skewed sex ratio were attributed to chance for these control females. Having conducted over 86 repro screening studies in 2010-2013 (either alone,
or in combination with 28-day repeated dose toxicity studies), WIL Research Europe has an extensive historical control database from animals of this same strain and supplier. As the data from the concurrent control group were not representative of the historical control data generated from this type of study, the data from the treated groups were also evaluated using the extensive historical control data available, and are included in the report. The extent and consistency of the historical control data allowed for a complete and thorough evaluation of the test substance on reproduction and
development. All reproductive and developmental data from treated groups remained within the range of historical control data available.
Key result
Dose descriptor:
NOAEL
Effect level:
>= 1 000 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: No adverse effects observed up to and including the highest dose tested.
Clinical signs:
no effects observed
Mortality / viability:
no mortality observed
Body weight and weight changes:
no effects observed
Sexual maturation:
no effects observed
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Histopathological findings:
not examined
VIABILITY (OFFSPRING)
Two pups at 100 mg/kg bw/day and two pups at 1000 mg/kg bw/day were missing during the first days of lactation; these pups were most likely cannibalised. No toxicological relevance was attributed to this since the mortality incidence did not show a dose-related trend and remained within the range considered normal for pups of this age.
One pup at 300 mg/kg bw/day was killed in extremis on Day 4 of lactation. This pup showed a wound on the left flank. At this single occurrence at the mid dose group, it was not considered toxicologically relevant.

CLINICAL SIGNS (OFFSPRING)
One pup at 300 mg/kg bw/day showed an affected snout (missing skin and scabs) and lean or pale appearance. A body weight loss was noted for this animal (5.0 gram on Day 1 and 3.8 gram on Day 4). One pup at 1000 mg/kg bw/day showed indentation of the head. At this low incidence, these findings were considered to be of no toxicological relevance.

BODY WEIGHT (OFFSPRING)
Body weights of pups were considered to have been unaffected by treatment.

OTHER FINDINGS (OFFSPRING)
Gestation
Gestation index was 100% for all groups and duration of gestation was similar among the groups.
Parturition/maternal care
No signs of difficult or prolonged parturition were noted among the pregnant females. Examination of cage debris of pregnant females revealed no signs of abortion or premature birth. No deficiencies in maternal care were observed. However it might be postulated that one dam probably caused the wound on the flank of the pup. At this single occurrence, it was considered a chance finding.
Early postnatal pup development
Number of dead and living pups at first litter check, postnatal loss, viability index and sex ratio were unaffected by treatment, and clinical signs, body weight and external macroscopy did not reveal treatment-related findings.
Key result
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
>= 1 000 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: No adverse effects observed up to and including the highest dose tested.
Reproductive effects observed:
not specified

Analysis of dose preparation.

- Accuracy of preparation: The concentrations analysed in the formulations of the doses of 100, 300 and 1000 mg/kg bw/day were in agreement with target concentrations (i.e. mean accuracies between 85% and 115%). No test substance was detected in the control formulation.

- Homogeneity: The formulations of the doses of 100 and 1000 mg/kg bw/day were homogeneous (i.e. coefficient of variation ≤ 10%).

- Stability: Formulations at the entire range were stable when stored at room temperature under normal laboratory light conditions for at least 6 hours.

Conclusions:
In an oral OECD 421 rat reproduction/developmental screening study, no parental, reproduction or developmental effects were observed up to and including the highest dose tested. Therefore, the NOAEL is determined to be >=1000 mg/kg bw/day.
Executive summary:

4,4’-(9H-fluoren-9-ylidene)bis(2-chloroaniline) was administered by daily oral gavage to male and female Wistar Han rats at dose levels of 0, 100, 300 and 1000 mg/kg bw/day according to OECD 421. Males were exposed for 2 weeks prior to mating, during mating, and up to termination (for 28 days). The females were exposed for 2 weeks prior to mating, during mating, during post-coitum, and at least 4 days of lactation (for 41-55 days). Formulation analysis showed that the formulations were prepared accurately and homogenously, and were stable for at least 6 hours at room temperature. No parental toxicity was observed up to and including the highest dose level tested (1000 mg/kg bw/day). No treatment-related changes were noted in any of the parental parameters investigated in this study (i.e. clinical appearance, body weight, food consumption, macroscopic examination, organ weights, and microscopic examination). No reproduction toxicity nor any treatment related changes in any of the reproductive parameters investigated in this study

(i.e. mating, fertility and conception indices, precoital time, and numbers of corpora lutea and implantation sites) were observed

up to and including the highest dose level tested (1000 mg/kg bw/day). No developmental toxicity nor any treatment related changes in any of the developmental parameters investigated in this study (i.e. gestation index and duration, parturition, maternal care and early postnatal pup development consisting of mortality, clinical signs, body weight and macroscopy) were observed up to and including the highest dose level tested. Based on these results, a parental, reproduction and developmental No Observed Adverse Effect Level (NOAEL) of at least 1000 mg/kg bw/day was derived.
Effect on fertility: via oral route
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
NOAEL
1 000 mg/kg bw/day
Study duration:
subacute
Species:
rat
Quality of whole database:
The available information comprises an adequate and reliable study (Klimisch score 1), and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.7, of Regulation (EC) No 1907/2006.
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available
Additional information

4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) (CAS 107934-68-9) was tested in a reproductive/developmental toxicity screening test according to OECD Guideline 421 (de Raaf-Beekhuijzen, 2013). The test substance was applied by gavage to Han-Wistar rats. 40 male and female animals per dose were treated with 100, 300 or 1000 mg/kg bw/day test substance dissolved in propylene glycol (5 mL/kg bw). Control animals received the vehicle only. Males were exposed for 28 days (2 weeks prior to mating, during mating, and up to the day prior to scheduled necropsy). Females were exposed for 41-55 days (during 2 weeks prior to mating, during mating, during post-coitum, and during at least 4 days of lactation. Observations and examinations of the animals included mortality/viability, clinical signs, body weight, food consumption and general reproduction data. Post-mortem examinations were conducted including macroscopic and histotechnological examinations and determination of organ weights.Thepups were sexed and descriptions of all external abnormalities were recorded. Relevant abnormalities were collected and fixed in formalin for further evaluation.

No mortality occurred during the study period. No clinical symptoms or signs were observed at any dose level during the study period, which were considered to be related to the test item. Incidental findings that were noted included scabbing, a wound, and alopecia. No test item-related changes were observed on body weight or food consumption. No treatment-related findings were observed at any dose level during macroscopic examination. No toxicologically relevant changes were noted in organ weights and organ to body weight ratios. The statistically significantly change noted for relative liver weight for males treated at 100 mg/kg bw was not considered toxicologically relevant as no dose response was noted and all values were within normal limits. No test item-related microscopic findings were observed. The spermatogenic staging profiles were normal for all males examined. Mating, fertility and conception indices, precoital time, and number of corpora lutea and implantation sites were unaffected by treatment. A total of 8 mated females were not pregnant: 4 in the control group, 2 treated at 100 mg/kg bw and 2 treated at 300 mg/kg bw which resulted in decreased fertility and conception indices for the control group. This was considered a chance finding and not treatment related as it mostly concerned the control group and at 1000 mg/kg bw all females were pregnant. The statistically significant increase for number of corpora lutea at 1000 mg/kg bw was not considered toxicologically relevant as all values were within normal limits, with the control group at the lower end.

As the control group consisted of six litters only, historical control data were added to this report to support a thorough evaluation of all developmental data. The extent and consistency of the historical control data allowed for a complete and thorough evaluation of the test substance on reproduction and development. All reproductive and developmental data from treated groups remained within the range of historical control data available.

In conclusion, treatment with 4,4’-(9H-fluoren-9-ylidene)bis(2-chloroaniline) by oral gavage in male and female Wistar Han rats at dose levels of 100, 300 and 1000 mg/kg bw revealed no parental and reproduction toxicity for treatment up to 1000 mg/kg bw. Based on these results, a parental and reproduction No Observed Adverse Effect Level (NOAEL) of at least 1000 mg/kg bw was derived.


Short description of key information:
Toxicity to reproduction:
Reproduction/developmental toxicity screening test (OECD 421), rat: NOAELmaternal ≥ 1000 mg/kg bw/day; NOAELreproduction ≥ 1000 mg/kg bw/day

Justification for selection of Effect on fertility via oral route:
The reliable GLP compliant OECD Guideline study was choosen.

Effects on developmental toxicity

Description of key information
Developmental toxicity:
Reproduction/developmental toxicity screening test (OECD 421), rat: NOAELmaternal ≥ 1000 mg/kg bw/day; NOAELdevelopmental ≥ 1000 mg/kg bw/day
Effect on developmental toxicity: via oral route
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
NOAEL
1 000 mg/kg bw/day
Study duration:
subacute
Species:
rat
Quality of whole database:
The available information comprises an adequate and reliable study, and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.7, of Regulation (EC) No 1907/2006.
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available
Additional information

4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) (CAS 107934-68-9) was tested in a reproductive/developmental toxicity screening test according to OECD Guideline 421 (de Raaf-Beekhuijzen, 2013). The test substance was applied by gavage to Han-Wistar rats. 40 male and female animals per dose were treated with 100, 300 or 1000 mg/kg bw/day test substance dissolved in propylene glycol (5 mL/kg bw). Control animals received the vehicle only. Males were exposed for 28 days (2 weeks prior to mating, during mating, and up to the day prior to scheduled necropsy). Females were exposed for 41-55 days (during 2 weeks prior to mating, during mating, during post-coitum, and during at least 4 days of lactation. Observations and examinations of the animals included mortality/viability, clinical signs, body weight, food consumption and general reproduction data. Post-mortem examinations were conducted including macroscopic and histotechnological examinations and determination of organ weights.Thepups were sexed and descriptions of all external abnormalities were recorded. Relevant abnormalities were collected and fixed in formalin for further evaluation.

No mortality occurred during the study period. No clinical symptoms or signs were observed at any dose level during the study period, which were considered to be related to the test item. Incidental findings that were noted included scabbing, a wound, and alopecia. No test item-related changes were observed on body weight or food consumption. No treatment-related findings were observed at any dose level during macroscopic examination. No toxicologically relevant changes were noted in organ weights and organ to body weight ratios. The statistically significantly change noted for relative liver weight for males treated at 100 mg/kg bw was not considered toxicologically relevant as no dose response was noted and all values were within normal limits. No test item-related microscopic findings were observed.

No toxicologically relevant effects on gestation index and duration, parturition, maternal care and early postnatal pup development (mortality, clinical signs, body weight and macroscopy) were observed. Gestation index was 100% for all groups and duration of gestation was similar among the groups. No signs of difficult or prolonged parturition were noted among the pregnant females. Examination of cage debris of pregnant females revealed no signs of abortion or premature birth. No deficiencies in maternal care were observed. However it might be postulated that dam no. 66 probably caused the wound on the flank of the pup. At this single occurrence, it was considered a chance finding. Number of dead and living pups at first litter check, postnatal loss, viability index and sex ratio were unaffected by treatment, and clinical signs, body weight and external macroscopy did not reveal treatment-related findings. Two pups at 100 mg/kg bw and two pups at 1000 mg/kg bw were missing during the first days of lactation; these pups were most likely cannibalised. No toxicological relevance was attributed to this since the mortality incidence did not show a dose-related trend and remained within the range considered normal for pups of this age. One pup at 300 mg/kg bw was killed in extremis on Day 4 of lactation. This pup showed a wound on the left flank. At this single occurrence at the mid dose group, it was not considered toxicologically relevant. A statistically significant change was noted for sex ratio at 1000 mg/kg bw. This was however not considered treatment related as the values were well within normal limits, with the control group at the outer limit. One pup at 300 mg/kg bw showed an affected snout (missing skin and scabs) and lean or pale appearance. A body weight loss was noted for this animal (5.0 gram on Day 1 and 3.8 gram on Day 4). One pup at 1000 mg/kg bw showed indentation of the head. At this low incidence, these findings were considered to be of no toxicological relevance. Body weights of pups were considered to have been unaffected by treatment.

As the control group consisted of six litters only, historical control data were added to this report to support a thorough evaluation of all developmental data. The extent and consistency of the historical control data allowed for a complete and thorough evaluation of the test substance on reproduction and development. All reproductive and developmental data from treated groups remained within the range of historical control data available.

In conclusion, treatment with 4,4’-(9H-fluoren-9-ylidene)bis(2-chloroaniline) by oral gavage in male and female Wistar Han rats at dose levels of 100, 300 and 1000 mg/kg bw revealed no parental and developmental toxicity for treatment up to 1000 mg/kg bw. Based on these results, a parental and developmental No Observed Adverse Effect Level (NOAEL) of at least 1000 mg/kg bw was derived.


Justification for selection of Effect on developmental toxicity: via oral route:
A study according to OECD 421 is available where no adverse effects were observed up to the highest dose tested (1000 mg/kg bw/day). The screening infomation is sufficient to meet the standard information requirements of Regulation (EC) 1907/2006, Annex VIII, Column I, 8.7.1., but does not fulfill the criteria for a reliable assessment of the endpoint developmental toxicity according to Regulation 1272/2008/EC.

Justification for classification or non-classification

A reproduction/developmental toxicity screening study according to OECD 421 is available where no adverse effects on toxicity to reproduction and development were observed up to the highest dose tested (1000 mg/kg bw/day). Although the screening infomation is sufficient to meet the standard information requirements of Regulation (EC) 1907/2006, Annex VIII, Column I, 8.7.1., it does not fulfill the criteria for a reliable assessment leading to a decision on classification or non-classification and labelling of the endpoint toxicity to reproduction/developmental toxicity according to Regulation 1272/2008/EC.

The available data on toxicity to reproduction/developmental toxicity of the test item are therefore inconclusive and insufficient for classification according to Regulation (EC) 1272/2008 or Directive 67/548/EEC.